SHIKARI® T-CAP Nab Assay™-Certolizumab ELISA Kit

Target Capture Neutralizing Antibodies Immunoassay-Certolizumab

This kit has been developed for detecting ‘Free’ neutralizing antibodies to certolizumab. The kit is composed of 4 different controls.
• Positive control: It contains netralizing antibody
• Negative control
• Cut-Off control: Contains certain amounted neutralizing antibody. Corresponse to lower limit of detection (LLOD)
• Non-Neutralizing Antibody Negative Control: Contains non-neutralizing antibodies binding to the drug
With these controls, the kit provides reliable results.

The Cut Off serum contains the LLOD amount and provides accurate true positive or negative results.
A non-neutralising antibody that binds to the drug without affecting the test results can be considered as a negative control.
The kit was also checked with various negative serum samples, including RF(+), CRP(+), ANA(+) sera. All these negative sera did not interfere with the test system. Please refer to the validation report.
We strictly recommend taking sample just before the next dose administration from the patient.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

Please contact us at for specific academic pricing.

More Details